Administrative information
TB
INFECTIOUS DISEASES

This Trial is under funding by Janssen Global Public Health, a division of Janssen Pharmaceutica NV, under grant number 1550786Turnhoutseweg 30, B-2340 Beerse, BelgiumClara Wekesa1. Infectious Diseases Institute, Makerere University2. Department of Public Health, Cambridge University3. TB unit, Mulago National Referral HospitalSA, CS, SZ, RPR and CW conceived the study, participated in the proposal and protocol development. SN wrote up the statistical methods of the study and IL contributed to development of the study tools. All authors read and approved the final manuscript.